Showing results (1511-1520 of 19,550) with videos related to
Sort By:
Pageof 1,955
BMC Cancer|August 24, 2025
A novel MRI-based habitat analysis and deep learning for predicting perineural invasion in prostate cancer: a two-center studyShuitang Deng, Danjiang Huang, Xiaoyu Han, et al.BMC Cancer|July 9, 2015
Polish experience of lenalidomide in the treatment of lower risk myelodysplastic syndrome with isolated del(5q)Aleksandra Butrym, Ewa Lech-Maranda, Elżbieta Patkowska, et al.BMC Cancer|July 8, 2015
Enhancing adherence in trials promoting change in diet and physical activity in individuals with a diagnosis of colorectal adenoma; a systematic review of behavioural intervention approachesDeborah McCahon, Amanda J Daley, Janet Jones, et al.BMC Cancer|July 15, 2015
Pan-cancer analysis of TCGA data reveals notable signaling pathwaysRichard Neapolitan, Curt M Horvath, Xia JiangBMC Cancer|July 15, 2015
Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Max Seidensticker, Benjamin Garlipp, Sophia Scholz, et al.BMC Cancer|April 25, 2015
Adult metanephric adenoma presumed to be all benign? A clinical perspectiveGang Li, Yuhong Tang, Renya Zhang, et al.BMC Cancer|April 18, 2015
Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancerNa Young Jang, Dan Hyo Kim, Bong Jun Cho, et al.BMC Cancer|April 18, 2015
Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancerMasaru Matsumoto, Masahiro Seike, Rintaro Noro, et al.BMC Cancer|April 18, 2015
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancerMao Ouyang, Hua Wang, Jieyi Ma, et al.BMC Cancer|April 18, 2015
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility studyTakashi Shigekawa, Akihiko Osaki, Hiroshi Sekine, et al.Pageof 1,955